Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
ABSTRACT A novel type of antibacterial screening method, a target mechanism-based whole-cell screening method, was developed to combine the advantages of target mechanism- and whole-cell-based approaches. A mycobacterial reporter strain with a synthetic phenotype for caseinolytic protease (ClpP1P2)...
Enregistré dans:
Auteurs principaux: | Wilfried Moreira, Grace J. Y. Ngan, Jian Liang Low, Anders Poulsen, Brian C. S. Chia, Melgious J. Y. Ang, Amelia Yap, Justina Fulwood, Umayal Lakshmanan, Jolander Lim, Audrey Y. T. Khoo, Horst Flotow, Jeffrey Hill, Ravikiran M. Raju, Eric J. Rubin, Thomas Dick |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/759d7a3e9b8f46bb802568696b32e7c6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
par: Yoshiyuki Yamada, et autres
Publié: (2017) -
Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021) -
Technical data on the inhibition properties of some medicinal plant extracts towards caseinolytic protease proteolytic subunit of Plasmodium knowlesi
par: Raimalynah Abd Razak, et autres
Publié: (2021) -
Ecology of Nontuberculous Mycobacteria
par: Joseph O. Falkinham
Publié: (2021) -
Pathogenic Mycobacteria in Water
par: World Health Organization